TGPSC Group-I 2022 · Question 95 of 140
science-tech
Biotech products: Interleukins — treating cancer (A-2); Insulin — treating diabetes (B-3); Tissue plasminogen activator — treating heart attacks/stroke (C-4); Blood factor VIII — treating haemophilia (D-1). Answer: (3).
Source: TGPSC Group-I 2022 Prelims (Master Paper, Notification No. 04/2022)
Practice the full TGPSC Group-I 2022 paper
Timed test with all 140 questions, just like the real exam.
Start test